Navigation Links
Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference
Date:11/26/2008

BETHESDA, Md., Nov. 26 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its President and Chief Executive Officer, Dr. Christian Itin, will present at the Piper Jaffray 20th Annual Health Care Conference at the New York Palace Hotel on Wednesday, December 3, 2008. A simultaneous webcast of the presentation will be available on the company's website at www.micromet-inc.com.


    Forum:      The Piper Jaffray 20th Annual Health Care Conference
    Date:       Wednesday, December 3, 2008
    Time:       1:30 pm, Eastern Time
    Place:      The New York Palace
                455 Madison Avenue
                New York, NY 10022
    Webcast:    www.micromet-inc.com

In addition, Dr. Itin will participate in a panel discussion titled "Novel Antibody Technologies," which will be held at the conference on the same day from 12:00 noon until 1:00 pm, eastern time.

About Micromet, Inc.

Micromet, Inc. (www.micromet-inc.com) is a biopharmaceutical company with offices in Bethesda, MD and Munich, Germany. The Company is focused on developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. The Company's novel antibody technology is based on its proprietary BiTE antibody platform, representing a new class of antibodies that specifically activate T cells from the patient's own immune system to eliminate cancer cells or other disease related cells. Four of the Company's antibodies are currently in clinical trials, with the remainder of its product pipeline
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
2. Micromets BiTE(R) Antibodies Reveal Unique Mode of Action
3. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
4. Micromet, Inc. Reports First Quarter 2008 Financial Results
5. Micromet, Inc. Reports Second Quarter 2008 Financial Results
6. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
7. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
8. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:7/22/2014)... 22, 2014 Cloud+MD Office 2.0 ... interoperable suite of medical software and services, designed ... providers, that produces “Actionable Information” to help Independent ... Systems and Billing Services optimize a wide range ... Quality, Greater Efficiency, Noticeable Cost Reductions and Better ...
(Date:7/22/2014)... For the past nine years, the LIVESTRONG Foundation ... tandem to help thousands of cancer patients and survivors ... help survivors connect to resources dealing with work discrimination ... to include referrals from PAF to LIVESTRONG to help ... emotional, and financial issues that accompany a diagnosis. ...
(Date:7/22/2014)... 22, 2014 Joining Conquer Paralysis Now as ... the next decade is Paralympic silver medalist and quadriplegic Jennifer ... became a quadriplegic from a spinal cord injury in 1998. ... a cure for paralysis. , “People define cure differently,” French ... something else. We have the image in our minds of ...
(Date:7/22/2014)... Hills, CA (PRWEB) July 22, 2014 ... document management and workflow solutions, announced today their Gold ... 28 – 31 at Mandalay Bay Hotel and Casino ... Sage customers, Sage Summit draws thousands interested in taking ... leaders, learn how to solve business problems and educate ...
Breaking Medicine News(10 mins):Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Cloud-MD Software will soon Receive MU2 Certification 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Paralympian Jen French Announced as Conquer Paralysis Now’s First Champion 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3
... that it's never too late for a person to start ... ,The researchers particularly taking into consideration the people who ... the exercise need not be of any strenuous nature but ... Dr Dietrich Rothenbacher, an epidemiologist at the University of Heidelberg ...
... variations on how hospitals spend for meals for their ... are spending four times the amounts spent by others.// ... average of ?61 on patients' meals per week as ... to The Scotsman newspaper, there are huge variations reported. ...
... be successfully located with or in pediatric practices, ... Medical Center and the N.C. Chapter of the ... journal Clinical Pediatrics, the researchers said, “With the ... mental health disorders in primary health care settings, ...
... therapy, when used to treat patients who are in ... chances of survival//, say researchers at Rhode Island ... patients over seven years, the median survival rate at ... to 42 months when thermal ablation was followed by ...
... his colleagues working in the laboratory of Dr. Stanley ... that controls// the sensitivity of human cancer cells to ... of research striving towards increased effectiveness of ... in advance of its scheduled August 1 publication date ...
... devised a chip that can be implanted into a patient's arm, ... medical personnel to easily get hold of patients' medical data. , ... have launched the program to test this product, which will go ... ,The chip can be interpreted with the ...
Cached Medicine News:Health News:Exercise Activities Helps To Avoid Heart Ailment 2Health News:Mental Health Providers Can Be Successfully Located With Pediatricians 2Health News:Combination Therapy to the Rescue off Lung Cancer Patients 2Health News:Combination Therapy to the Rescue off Lung Cancer Patients 3
(Date:7/21/2014)... Israel , July 21, 2014 ... "Integrity"), developer of the GlucoTrack ® model ... that it has entered, through its wholly-owned subsidiary, ... Wistron Corp, the manufacturing arm of Acer Inc.  ... manufacture and service (on a non-exclusive basis) the ...
(Date:7/21/2014)... JOLLA, Calif. , July 21, 2014 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that the U.S. Food & Drug Administration (FDA) ... single stranded, chemically modified oligonucleotide that binds to ... a therapeutic for the treatment of Alport syndrome, ...
(Date:7/21/2014)... DIEGO , July 21, 2014  An International ... a redesign of its iCH CPAP device, Taiwanese device ... humidification. ResMed (NYSE: RMD ) is the ... for the treatment of sleep-disordered breathing. ... improving designs to reach new levels of comfort, performance ...
Breaking Medicine Technology:Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 2Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2
... OSLO, Norway, October 31, 2011 Oslo ... oncology. The true strength of the Norwegian cluster lies ... than the ones available to cancer patients today. ... cluster within the field of oncology, dedicated to accelerating ...
... Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and ... (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee ... 01 Blood Glucose Meters as the first and second ... of service as noted by the Uniform Formulary Beneficiary ...
Cached Medicine Technology:Expanding Norwegian Cluster of Excellence Dedicated to Oncology 2Expanding Norwegian Cluster of Excellence Dedicated to Oncology 3ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary. 2
... Shepard Clear Corneal Diamond Knife is a ... Dennis Shepard of Santa Maria, California. This ... Shepard's need for a quality instrument that ... Corneal Surgical technique. Through professional collaboration between ...
The new TRC-NW200 Non-Mydriatic Retinal Camera combines Topcons years of experience in retinal imaging with the latest advances in digital and electronic technology....
... Software is a new approach to practice management, ... face in todays healthcare market. OPIE was created ... who work exclusively in this field, so it ... functional and easy-to-use than anything else available. If ...
... The DioLite 532 laser is ... and pigmented skin lesions such as ... port wine stains, lentigines, dermatosis papulosis ... technology offers unsurpassed reliability, a selection ...
Medicine Products: